SPEAKER_04

There it is.

Yeah.

And so, yeah, it looks weird, doesn't it?

And so the expert told me, okay, I need this view of an x-ray, this view, this view, this view.

And so we got that and it came back and it said, okay, well, you know, we need to get some DNA sequencing, he said.

I said, okay.

So we got a piece of the bone from actually the rib.

And the rib was important to use because that would be, I felt, an area that would be least likely to be contaminated by bacterial, you know, degradation.

And so I got a little bit of bone marrow out and I did the sequencing.

Long story short, I had to bring in, once I'd done that, there was a lot of DNA that didn't make sense, but it's old DNA.

It wasn't that old actually, but it was degraded.

So I had to bring in experts at Stanford who knew how to fix the degradation.

And then I had to bring in an expert in South American genetics who also happened to be at Stanford.

And then we brought in a team of students.

And then I brought in Roche Diagnostics.

I had sold a sequencing company to Roche about a few years earlier.

So I brought in the team that actually knew how to help me assemble the genome.

And then we published a paper which said it's human.

It was a female.

And here are some mutations that might explain what it looked like.